UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 13, 2020 9:00 A.M.
Form:
S-3
CIK:
0001645469
Company Name:
Monopar Therapeutics
File Number:
333-235791